COVID-19 has hit provider organizations hard with challenges including lost revenue, reduced staff, and uncontrolled chronic conditions while the most critical patients avoid care. Population health leaders, especially those in value-based contracts, face a fourth challenge: rising-risk patients.
Under the status quo, providers rely on manual traditional care management and device-based technology that does not scale to reach sufficient populations. As a result, providers lack the ability to proactively reach a large and costly population-rising-risk patients, and lose timely opportunities to bend the cost curve and prevent rising-risk patients from becoming high-cost utilizers.
Simply put: It’s not enough to focus on high-risk patients alone.
Read our white paper to learn 5 Strategies for Improving Clinical and Financial Outcomes During and Post-Pandemic, as well as real life examples how CareSignal client-partners have successfully implemented these strategies and scaled Deviceless RPM.
By filling out this form you are opting in to receive communications from MedCity News and its partners.
Providers are planning a post-pandemic future with deviceless remote patient monitoring
Learn the 5 Strategies to Scale Outcomes and ROI to Rising-Risk Populations During and After the Pandemic